Role of Host and Parasite MIF Cytokines during Leishmania Infection

Tropical Medicine and Infectious Disease

Richard Bucala¹  Thomas Holowka¹ 

[1] Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA;

关键词: leishmania;    mif;    inflammation;    immunization;   

DOI  :  10.3390/tropicalmed5010046

来源: DOAJ

【 摘 要 】

Macrophage migration inhibitory factor (MIF) is an immunoregulatory cytokine that has been extensively characterized in human disease and in mouse models. Its pro-inflammatory functions in mammals includes the retention of tissue macrophages and a unique ability to counteract the immunosuppressive activity of glucocorticoids. MIF also acts as a survival factor by preventing activation-induced apoptosis and by promoting sustained expression of inflammatory factors such as TNF-α and nitric oxide. The pro-inflammatory activity of MIF has been shown to be protective against Leishmania major infection in mouse models of cutaneous disease, however the precise role of this cytokine in human infections is less clear. Moreover, various species of Leishmania produce their own MIF orthologs, and there is evidence that these may drive an inflammatory environment that is detrimental to the host response. Herein the immune response to Leishmania in mouse models and humans will be reviewed, and the properties and activities of mammalian and Leishmania MIF will be integrated into the current understandings in this field. Furthermore, the prospect of targeting Leishmania MIF for therapeutic purposes will be discussed.

【 授权许可】

Unknown